NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Retatrutide from Kerui Peptide HongKong? Mail in a sample (US only) and let us test it.

Test my supply
+12 more ↓
66%
Finnrick rating
#387 of 419 Retatrutide vendors
13 of 21 classifiable tests passed
natural 62% · customers 4.1★ (40)
methodology · Purity focus
Finnrick analysis · Retatrutide

Kerui's Retatrutide evidence is volatile, with identity failures and major purity/quantity misses pulling this rating down. Recent records include 42.4% purity with -58% fill and another -58% fill before two later passes.

methodology →
vendor intelligence report
Vendor Intelligence Report: Kerui Peptide HongKong

A live Hong Kong company record is real, but WHOIS, hosting paths, and forum placement point away from a simple Hong Kong operating story. The report maps the Emily-KR/Iris1 sales trail, payment rails, and GLP-1 enforcement exposure.

22 pages5 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.07
88%
4
2
Tirzepatide
$0.54
75%
7
3
Retatrutideselected
$0.70
66%
21
4
BPC-157
$0.66
53%
5
5
Tesamorelin
$2.00
49%
4
6
TB-500
$2.00
38%
3
7
NAD+
$0.01
22%
4
8
5-Amino-1MQ
$0.17
-
0
9
Cagrilintide
$2.72
-
0
10
CJC-1295
$2.38
-
0
12
GLOW
$0.29
-
0
13
Glutathione
$0.01
-
0
14
Ipamorelin
$0.74
-
0
15
KLOW
$0.23
-
0
16
KPV
$0.54
-
0
17
MOTS-c
$0.53
-
0
19
PT-141
-
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%3 Jul 2025: 64%29 Jan 2026: 74%20 May 2026: 78%20 May 2026: 74%20 May 2026: 70%28 May 2026: 71%2 Jun 2026: 67%10 Jul 2026: 68%3 Aug 2026: 69%13 Aug 2026: 70%15 Aug 2026: 72%26 Aug 2026: 73%28 Aug 2026: 69%15 Sep 2026: 70%18 Sep 2026: 71%20 Sep 2026: 73%5 Oct 2026: 69%28 Oct 2026: 66%2 Nov 2026: 64%6 Nov 2026: 65%10 Nov 2026: 66%15 Nov 2026: current 66%64%74%66%Jul 25Nov 26
Showing Retatrutide tests only
Peptide testing

Ordered Retatrutide from Kerui Peptide HongKong? Mail in a sample (US only) and let us test it.

Test my supply
Kerui Peptide HongKong Retatrutide test history
COA-backed lab tests
1-10 of 21

About Kerui Peptide HongKong test results from Finnrick

Kerui Peptide HongKong is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 48 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Kerui Peptide HongKong peptides in this dataset are BPC-157 (5 tests), GHK-Cu (4 tests) and NAD+ (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 48 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Retatrutide from Kerui Peptide HongKong? Mail in a sample (US only) and let us test it.

Test my supply